<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">brhejo</journal-id><journal-title-group><journal-title xml:lang="en">The BRICS Health Journal</journal-title><trans-title-group xml:lang="ru"><trans-title>The BRICS Health Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">3034-4700</issn><issn pub-type="epub">3034-4719</issn><publisher><publisher-name>Sechenov University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47093/3034-4700.2025.2.1.3-12</article-id><article-id custom-type="elpub" pub-id-type="custom">brhejo-19</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Brazilian legislation on innovation policy: a brief history</article-title><trans-title-group xml:lang="ru"><trans-title></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3770-7504</contrib-id><name-alternatives><name name-style="western" xml:lang="en"><surname>Gram</surname><given-names>K. R.</given-names></name></name-alternatives><bio xml:lang="en"><p>Karla Regina da Silva Gram, Dr., MSc, Sp., Doctoral Student, Universidade Federal do Rio de Janeiro, Tuberculosis Academic Program of the Faculty of Medicine; Clinical Research Project Manager, Fundação Oswaldo Cruz, Vice-Presidência de Pesquisa e Coleções Biológicas.</p><p>Rua Professor Rodolpho Paulo Rocco, 255 – 6° andar, Cidade Universitária, Rio de Janeiro, RJ, 21.941-913, Brasil</p><p>Avenida Brasil, 4365, Pavilhão Mourisco, sala 13, Manguinhos, Rio de Janeiro, RJ, 21.040-900, Brasil</p><p> </p></bio><email xlink:type="simple">karla.gram@limulus.com.br</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5900-6007</contrib-id><name-alternatives><name name-style="western" xml:lang="en"><surname>Kritski</surname><given-names>A.</given-names></name></name-alternatives><bio xml:lang="en"><p>Afrânio Lineu Kritski, Dr., PhD, Full Professor of Phthisiology and Pulmonology, Coordinator of the Tuberculosis Academic Program at the School of Medicine and the hospital complex of the Hospital Universitário Clementino Fraga Filho/Instituto de Doenças do Tórax, Universidade Federal do Rio de Janeiro, Tuberculosis Academic Program of the Faculty of Medicine.</p><p> Rua Professor Rodolpho Paulo Rocco, 255 – 6° andar, Cidade Universitária, Rio de Janeiro, RJ, 21.941-913, Brasil</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0064-387X</contrib-id><name-alternatives><name name-style="western" xml:lang="en"><surname>De Oliveira</surname><given-names>M. M.</given-names></name></name-alternatives><bio xml:lang="en"><p>Martha Maria de Oliveira, Dr., PhD, Specialist in Science, Technology, Production and Innovation in Public Health, Fundação Oswaldo Cruz, Centro de Desenvolvimento Tecnológico em Saúde.</p><p>Avenida Brasil, 4036 (Campus Maré), Prédio da Expansão, 8° andar, sala 814, Manguinhos, Rio de Janeiro, RJ, 21040-361,  Brasil</p><p> </p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5695-2746</contrib-id><name-alternatives><name name-style="western" xml:lang="en"><surname>Marchini</surname><given-names>F.</given-names></name></name-alternatives><bio xml:lang="en"><p>Fabricio Klerynton Marchini, PhD, Dr., Technological Development Manager, Instituto de Biologia Molecular do Paraná; Fundação Oswaldo Cruz, Instituto Carlos Chagas. </p><p>Rua Professor Algacyr Munhoz Mader, 3775, Cidade Industrial de Curitiba, Curitiba, PR, 81350-010, Brasil; </p><p>Rua Professor Algacyr Munhoz Mader, 3775, Cidade Industrial de Curitiba, Curitiba, PR, 81350-020, Brasil</p></bio><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff xml:lang="en" id="aff-1"><institution>Universidade Federal do Rio de Janeiro; &#13;
Fundação Oswaldo Cruz</institution><country>Brazil</country></aff><aff xml:lang="en" id="aff-2"><institution>Universidade Federal do Rio de Janeiro</institution><country>Brazil</country></aff><aff xml:lang="en" id="aff-3"><institution>Fundação Oswaldo Cruz, Centro de Desenvolvimento Tecnológico em Saúde</institution><country>Brazil</country></aff><aff xml:lang="en" id="aff-4"><institution>Instituto de Biologia Molecular do Paraná; &#13;
Fundação Oswaldo Cruz, Instituto Carlos Chagas</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>20</day><month>05</month><year>2025</year></pub-date><volume>2</volume><issue>1</issue><fpage>3</fpage><lpage>12</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Gram K.R., Kritski A., de Oliveira M.M., Marchini F., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Gram K.R., Kritski A., de Oliveira M.M., Marchini F.</copyright-holder><copyright-holder xml:lang="en">Gram K.R., Kritski A., de Oliveira M.M., Marchini F.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.bricshealthjournal.com/jour/article/view/19">https://www.bricshealthjournal.com/jour/article/view/19</self-uri><abstract><p>Innovation is essential for socio-economic progress, particularly in today's fiercely competitive global environment. This article's primary focus is to review the evolution of Brazilian regulations on innovation policy, a subject of intense debate by the government and academic and business institutions. The goal is to review this evolution and dissect the key regulatory frameworks, policies, and initiatives shaping the current scenario. Qualitative research is carried out in three stages: searching and selecting documents, reading and categorizing sources and records, and reviewing relevant information. Since the 2000s, Brazil has promoted legislative reforms to modernize the mechanisms to encourage research and development, such as the Legal Framework for Innovation (2004), the inclusion of the term innovation in the Federal Constitution (2015), the new Legal Framework for Innovation (2016) and the National Policy for Technological Innovation in Health (2017). These changes enhance legal certainty and tax benefits for collaborations between companies and Science, Technology, and Innovation Institutions. Despite the progress, it is still crucial for Brazilian institutions to adopt more robust innovation </p><p>policies and more effectively align them with national development policies. Recently, the country intensified its innovation efforts by summarizing the Health Economic-Industrial Complex, integrated with the New Industrialization Policy, focused on economic, social, and sustainable development, highlighting public health. Brazil's evolution in innovation policy is a testament to the nation's steadfast commitment to technological and economic progress. While significant strides have been made, greater integration between institutions is imperative to maximize the benefits of innovation.</p></abstract><kwd-group xml:lang="en"><kwd>innovation</kwd><kwd>innovation policy</kwd><kwd>innovation regulations</kwd><kwd>public health</kwd><kwd>normative evolution</kwd><kwd>Brazilian regulations</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Bardin L. Análise de Conteúdo. 1st Edition. São Paulo, Brasil: Edições 70. 2015; 288 p.</mixed-citation><mixed-citation xml:lang="en">Bardin L. Análise de Conteúdo. 1st Edition. São Paulo, Brasil: Edições 70. 2015; 288 p.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Chesbrough HW. Open Innovation: The New Imperative for Creating and Profiting from Technology. Boston, Massachusetts: Harvard Business School Press. 2003; 227 p.</mixed-citation><mixed-citation xml:lang="en">Chesbrough HW. Open Innovation: The New Imperative for Creating and Profiting from Technology. Boston, Massachusetts: Harvard Business School Press. 2003; 227 p.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
